Israel Cancer Research Fund (ICRF) - Montreal

Founded in 1975, ICRF is a non profit organization consisting of physicians, scientists and volunteers who are dedicated to supporting innovative cancer research in Israel and locally in Montreal. Together we can find a cure! Since its inception, ICRF has raised over $98 million USD to support groundbreaking Israeli cancer research and has funded over 2,885 cancer research projects. The results of these research projects have a significant impact in Montreal, across Canada and throughout the world. Our rigorous grantmaking process is overseen by our volunteer Scientific Review Panel (SRP), a group of leading physicians and scientists from major research institutions throughout North America. These prominent, internationally renowned, professionals collectively donate thousands of hours to review each grant application in an intensive peer-review process. Today, ICRF is the largest nongovernmental source of cancer research funding in Israel. ICRF-funded scientists have been instrumental in the development of breakthrough FDA-approved drugs Gleevec©, Doxil© and Velcade© and include the first two Israeli Nobel Prize Laureates in Chemistry. ICRF grantees continue to make major cancer research breakthroughs and are at the forefront of discoveries in nano-medicine, immunotherapy, stem cell research and targeted therapies. In Montreal, we have successfully created over 30 fellowship positions in Montreal hospitals, in areas such as paediatric blood cancer, colorectal cancer, breast cancer and other cancer therapies. We currently fund six (6) post-doctoral fellows in local laboratories. In Israel, ICRF funds scientists at Israel's top biomedical research centres, including the Weizmann Institute of Science and Tel Aviv University. The areas of research focus are: Ovarian, Endometrial, Prostate, Thoracic & Upper GI, Orthopaedic, Pediatric Hematology, BRCA1 and BRCA2 Liver, Melanoma and Immunotherapy.